Vernon K. Sondak, Jonathan S. Zager, Ragini Kudchadkar
Oxford University Press, 2016 - Melanoma - 166 pages
Melanoma is a concise handbook that identifies best-practice guidelines and presents the most current procedures for the diagnosis and management of melanoma in a succinct and easy-to-read manner. Chapters cover melanoma pathology, biopsy techniques, staging and risk stratification, surgical treatment of localized melanoma, immunotherapy, radiation therapy, and guidelines for resected melanoma, targeted therapy, cytotoxic chemotherapy, and management of brain metastases, mucosal and ocular melanoma, and pediatric melanoma patients. This handbook is a must-have tool for clinicians directly involved in the care of patients with melanoma, including surgical oncologists, medical oncologists, and radiation oncologists.
What people are saying - Write a review
We haven't found any reviews in the usual places.
1 Epidemiology Risk Factors and Clinical Presentation of Melanoma
2 Melanoma Pathology
3 Biopsy Techniques for Melanoma
4 Melanoma Staging and Risk Stratification
5 Surgical Treatment of Melanoma
6 Immunotherapy in Melanoma
Other editions - View all
Melanoma: Translational Research and Emerging Therapies
Sanjiv S. Agarwala,Vernon K. Sondak
Limited preview - 2008
adjuvant advanced melanoma AJCC Ann Surg atypical Balch CM BRAF inhibitors Breslow carboplatin cells chemotherapy cisplatin Clin Oncol clinical trials cutaneous melanoma cytotoxic dabrafenib dacarbazine Dermatol dermis desmoplastic melanoma disease dose evaluation excisional biopsy follow-up fotemustine gene high-dose immunotherapy improved increased interferon interleukin-2 invasion ipilimumab kinase lesions lymph node biopsy lymphadenectomy malignant melanoma margins mela melanocytic melanoma brain metastases melanoma patients Melanoma Res melanoma staging metastatic melanoma microstaging molecular mucosal melanoma mutations nevi nevus nodal basin Nodular Melanoma noma Oncology paclitaxel patients with melanoma patients with metastatic patients with stage pediatric phase II trial pigmented primary melanoma primary tumor prognostic factors protein radiation therapy radiosurgery randomized recurrence regimen resection response rate retrospective risk sentinel lymph node sentinel node shave biopsy skin SLNB staging system subtype surgery surgical surveillance survival rates targeted temozolomide thickness toxicity treatment tumor ulceration uveal melanoma vemurafenib versus WBRT